Hugh Wang

Hugh (Zhengyuan) Wang is a seasoned professional in bioinformatics with extensive experience in precision medicine, biomarker discovery, and multi-omics data analysis. Currently serving as the Director of Bioinformatics at Summit Therapeutics since October 2021, Wang previously held the position of Associate Director of Bioinformatics at Ambry Genetics, focusing on AI/ML applications for clinical genomics. Prior roles include Principal/Senior Bioinformatics Scientist at AbbVie, where novel NGS data variant detection was a focus, and Senior Bioinformatics Engineer at Genomic Health Inc., with an emphasis on cancer biomarker pipeline development. Wang began a career in bioinformatics as a scientist at Kyowa Hakko Kirin California, AnaptysBio, and Washington University in St. Louis School of Medicine. Wang holds a PhD in Computational Biology from Louisiana State University and a Bachelor of Science in Genetics from Wuhan University.